Elevance Health, Inc. ELV
NYSE
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.81% | 0.46% | |||
| Total Other Revenue | 2.32% | 1.18% | |||
| Total Revenue | 1.89% | 0.58% | |||
| Cost of Revenue | 2.04% | 3.96% | |||
| Gross Profit | 1.49% | -7.66% | |||
| SG&A Expenses | 3.03% | -6.39% | |||
| Depreciation & Amortization | -3.64% | -1.79% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.25% | 1.37% | |||
| Operating Income | -5.69% | -13.53% | |||
| Income Before Tax | -7.38% | -15.93% | |||
| Income Tax Expenses | -6.63% | -11.21% | |||
| Earnings from Continuing Operations | -7.63% | -17.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 144.44% | 125.00% | |||
| Net Income | -6.70% | -17.06% | |||
| EBIT | -5.69% | -13.53% | |||
| EBITDA | -5.02% | -11.54% | |||
| EPS Basic | -6.53% | -15.99% | |||
| Normalized Basic EPS | -5.17% | -14.45% | |||
| EPS Diluted | -6.56% | -16.13% | |||
| Normalized Diluted EPS | -5.21% | -14.57% | |||
| Average Basic Shares Outstanding | -0.18% | -1.27% | |||
| Average Diluted Shares Outstanding | -0.14% | -1.13% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.07% | 0.20% | |||